393 related articles for article (PubMed ID: 29803828)
1. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
Giralt A; de Pins B; Cifuentes-Díaz C; López-Molina L; Farah AT; Tible M; Deramecourt V; Arold ST; Ginés S; Hugon J; Girault JA
Exp Neurol; 2018 Sep; 307():62-73. PubMed ID: 29803828
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
[TBL] [Abstract][Full Text] [Related]
3. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
5. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
6. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.
Liu P; Reichl JH; Rao ER; McNellis BM; Huang ES; Hemmy LS; Forster CL; Kuskowski MA; Borchelt DR; Vassar R; Ashe KH; Zahs KR
J Alzheimers Dis; 2017; 56(2):743-761. PubMed ID: 28059792
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer's disease.
Kaminari A; Giannakas N; Tzinia A; Tsilibary EC
Sci Rep; 2017 Apr; 7(1):683. PubMed ID: 28386117
[TBL] [Abstract][Full Text] [Related]
10. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
Moon M; Cha MY; Mook-Jung I
J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
[TBL] [Abstract][Full Text] [Related]
11. Microsomal prostaglandin E synthase-1 is induced in alzheimer's disease and its deletion mitigates alzheimer's disease-like pathology in a mouse model.
Akitake Y; Nakatani Y; Kamei D; Hosokawa M; Akatsu H; Uematsu S; Akira S; Kudo I; Hara S; Takahashi M
J Neurosci Res; 2013 Jul; 91(7):909-19. PubMed ID: 23553915
[TBL] [Abstract][Full Text] [Related]
12. Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.
Li C; Götz J
J Alzheimers Dis; 2018; 64(1):205-221. PubMed ID: 29782321
[TBL] [Abstract][Full Text] [Related]
13. Phloroglucinol ameliorates cognitive impairments by reducing the amyloid β peptide burden and pro-inflammatory cytokines in the hippocampus of 5XFAD mice.
Yang EJ; Mahmood U; Kim H; Choi M; Choi Y; Lee JP; Cho JY; Hyun JW; Kim YS; Chang MJ; Kim HS
Free Radic Biol Med; 2018 Oct; 126():221-234. PubMed ID: 30118828
[TBL] [Abstract][Full Text] [Related]
14. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
[TBL] [Abstract][Full Text] [Related]
15. Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.
Lee S; Salazar SV; Cox TO; Strittmatter SM
J Neurosci; 2019 Mar; 39(10):1910-1929. PubMed ID: 30626696
[TBL] [Abstract][Full Text] [Related]
16. Diesel engine exhaust accelerates plaque formation in a mouse model of Alzheimer's disease.
Hullmann M; Albrecht C; van Berlo D; Gerlofs-Nijland ME; Wahle T; Boots AW; Krutmann J; Cassee FR; Bayer TA; Schins RPF
Part Fibre Toxicol; 2017 Aug; 14(1):35. PubMed ID: 28854940
[TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
18. Vortioxetine administration attenuates cognitive and synaptic deficits in 5×FAD mice.
Jiang LX; Huang GD; Su F; Wang H; Zhang C; Yu X
Psychopharmacology (Berl); 2020 Apr; 237(4):1233-1243. PubMed ID: 31953648
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
[TBL] [Abstract][Full Text] [Related]
20. Gad67 haploinsufficiency reduces amyloid pathology and rescues olfactory memory deficits in a mouse model of Alzheimer's disease.
Wang Y; Wu Z; Bai YT; Wu GY; Chen G
Mol Neurodegener; 2017 Oct; 12(1):73. PubMed ID: 29017573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
